It has been a mixed year for Intellia Therapeutics, Inc. insiders: $1.4 million bought by one person and $2.2 million sold by seven, so more selling than buying overall.
Cohen Fred E (Director) made the biggest buy, worth around $1.4 million.
Last full quarter: net selling by insiders. Insiders bought in 2 of the last 7 full quarters. Big money check: 328 institutions held NTLA as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Dube Michael P | Executive Officer | Sell | 1,864 | $12.43 | $23K | SEC |
| Aug 24, 2026 | LEONARD JOHN M | CEO | Sell | 2,785 | $13.00 | $36K | SEC |
| Aug 24, 2026 | LEONARD JOHN M | CEO | Sell | 19,890 | $12.60 | $251K | SEC |
| Jul 24, 2026 | Dulac Edward J III | CFO | Sell | 8,111 | $11.25 | $91K | SEC |
| Jul 6, 2026 | Dube Michael P | Executive Officer | Sell | 2,641 | $16.78 | $44K | SEC |
| Jul 6, 2026 | Dulac Edward J III | CFO | Sell | 4,677 | $18.00 | $84K | SEC |
| Mar 3, 2026 | BASTA JAMES | Executive Officer | Sell | 1,211 | $13.78 | $17K | SEC |
| Mar 3, 2026 | Clark Eliana | Executive Officer | Sell | 607 | $13.78 | $8K | SEC |
| Jan 7, 2026 | LEONARD JOHN M | CEO | Sell | 34,146 | $9.21 | $314K | SEC |
| Jan 7, 2026 | Schultes Birgit C | Executive Officer | Sell | 8,508 | $9.21 | $78K | SEC |
| Jan 7, 2026 | BASTA JAMES | Executive Officer | Sell | 10,397 | $9.21 | $96K | SEC |
| Jan 7, 2026 | Cohen Fred E | Director | Buy | 150,000 | $9.35 | $1.4M | SEC |
| Jan 7, 2026 | Lebwohl David | Executive Officer | Sell | 11,903 | $9.21 | $110K | SEC |
| Jan 7, 2026 | Clark Eliana | Executive Officer | Sell | 9,515 | $9.21 | $88K | SEC |
| Jan 7, 2026 | Dube Michael P | Executive Officer | Sell | 2,989 | $9.21 | $28K | SEC |
In the last 12 months Intellia Therapeutics, Inc. insiders made open-market purchases worth about $1.4 million and sales worth about $2.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in NTLA was filed on 2026-10-06.
328 investment managers reported holding NTLA in SEC Form 13F filings for Q2 2026.
No congressional trades in NTLA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).